X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1356771) 1356771
Book Review (153783) 153783
Publication (102701) 102701
Newsletter (43700) 43700
Newspaper Article (9360) 9360
Book Chapter (8720) 8720
Conference Proceeding (8656) 8656
Magazine Article (3828) 3828
Dissertation (2142) 2142
Trade Publication Article (1284) 1284
Web Resource (1262) 1262
Government Document (886) 886
Book / eBook (841) 841
Transcript (440) 440
Reference (212) 212
Paper (132) 132
Data Set (84) 84
Technical Report (55) 55
Streaming Video (53) 53
Journal / eJournal (29) 29
Presentation (9) 9
Report (8) 8
Library Holding (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1092526) 1092526
humans (685343) 685343
animals (539587) 539587
male (355324) 355324
female (274234) 274234
rats (196496) 196496
mice (181881) 181881
biochemistry & molecular biology (167302) 167302
pharmacology & pharmacy (152020) 152020
middle aged (130662) 130662
adult (116766) 116766
oncology (105477) 105477
inhibitors (104989) 104989
aged (99197) 99197
enzyme inhibitors - pharmacology (98135) 98135
research (94917) 94917
expression (93713) 93713
cancer (88419) 88419
dose-response relationship, drug (84679) 84679
cell biology (83988) 83988
analysis (80356) 80356
abridged index medicus (78322) 78322
apoptosis (77101) 77101
cells, cultured (76900) 76900
cell line, tumor (69206) 69206
proteins (67119) 67119
neurosciences (67060) 67060
chemistry, medicinal (65437) 65437
kinetics (64229) 64229
time factors (64023) 64023
treatment outcome (61733) 61733
activation (59814) 59814
inhibitor (56784) 56784
cell line (56475) 56475
cells (56222) 56222
rats, sprague-dawley (54864) 54864
phosphorylation (54485) 54485
article (54378) 54378
care and treatment (51394) 51394
in vitro techniques (50754) 50754
inhibition (50142) 50142
structure-activity relationship (50068) 50068
signal transduction (49113) 49113
immunology (47606) 47606
chemistry, organic (46523) 46523
health aspects (44831) 44831
physiological aspects (44364) 44364
in-vitro (43962) 43962
risk factors (43741) 43741
molecular sequence data (43158) 43158
enzymes (42791) 42791
hematology (41746) 41746
drug therapy (41124) 41124
apoptosis - drug effects (40976) 40976
gene expression (40757) 40757
therapy (40138) 40138
amino acid sequence (39283) 39283
rats, wistar (38776) 38776
mutation (38412) 38412
cardiac & cardiovascular systems (37952) 37952
disease models, animal (37437) 37437
antineoplastic agents - pharmacology (37395) 37395
binding sites (36184) 36184
signal transduction - drug effects (35975) 35975
inflammation (35957) 35957
protein binding (35865) 35865
physiology (34552) 34552
peripheral vascular disease (33851) 33851
mice, inbred c57bl (33824) 33824
models, molecular (33688) 33688
molecular structure (33354) 33354
protease inhibitors (33340) 33340
in-vivo (32987) 32987
endocrinology & metabolism (32514) 32514
enzyme inhibitors (32480) 32480
medicine, research & experimental (32104) 32104
aged, 80 and over (32022) 32022
chemistry, multidisciplinary (31505) 31505
protein (31057) 31057
multidisciplinary sciences (30763) 30763
biophysics (30676) 30676
cell proliferation - drug effects (30257) 30257
binding (30214) 30214
drug therapy, combination (29703) 29703
gene-expression (29693) 29693
tumor cells, cultured (29552) 29552
medicine, general & internal (29461) 29461
blotting, western (29212) 29212
growth (28229) 28229
oxidative stress (28192) 28192
medicine & public health (27974) 27974
adolescent (27688) 27688
research article (27516) 27516
drugs (27458) 27458
disease (27200) 27200
genetic aspects (27061) 27061
derivatives (26682) 26682
identification (26645) 26645
immunohistochemistry (26219) 26219
medicine (25994) 25994
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (465) 465
Online Resources - Online (392) 392
Collection Dvlpm't (Acquisitions) - Vendor file (68) 68
Collection Dvlpm't (Acquisitions) - Closed Orders (45) 45
UofT at Mississauga - Stacks (29) 29
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (14) 14
Engineering & Comp. Sci. - Stacks (12) 12
UTL at Downsview - May be requested (12) 12
Chemistry (A D Allen) - Stacks (9) 9
Gerstein Science - Theses (7) 7
Gerstein Science - Periodical Stacks (6) 6
UofT at Scarborough - Stacks (6) 6
Earth Sciences (Noranda) - Stacks (5) 5
Robarts - Stacks (5) 5
Scarborough Hospital - General (3) 3
Collection Dvlpm't (Acquisitions) - Cancelled Order (2) 2
Gerstein Science - Missing (2) 2
Scarborough Hospital - Online (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
University Archives - Archives (2) 2
University College (Laidlaw) - Stacks (2) 2
Baycrest Hospital - Stacks (1) 1
Chemistry (A D Allen) - May be requested in 6-10 wks (1) 1
Gerstein Science - Bindery (1) 1
Gerstein Science - Circulation Desk (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Knox College (Caven) - Stacks (1) 1
Lakeridge Health Sciences - Online (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Media Commons - Audio Visual (1) 1
Patient Education (1) 1
Pharmacy (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
St. Michael's Hospital - Stacks (1) 1
UofT Schools - Stacks (1) 1
UofT at Scarborough - May be requested in 6-10 wks (1) 1
UofT at Scarborough - Withdrawn (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1350824) 1350824
German (13804) 13804
Russian (12754) 12754
French (11856) 11856
Japanese (9964) 9964
Chinese (9682) 9682
Spanish (5586) 5586
Italian (2950) 2950
Polish (2496) 2496
Korean (1489) 1489
Portuguese (1434) 1434
Czech (974) 974
Hungarian (772) 772
Dutch (771) 771
Swedish (567) 567
Danish (559) 559
Ukrainian (494) 494
Norwegian (402) 402
Turkish (371) 371
Romanian (232) 232
Finnish (231) 231
Slovak (213) 213
Croatian (193) 193
Hebrew (175) 175
Bulgarian (165) 165
Serbian (114) 114
Lithuanian (61) 61
Slovenian (53) 53
Persian (42) 42
Indonesian (25) 25
Icelandic (19) 19
Bosnian (18) 18
Greek (11) 11
Afrikaans (8) 8
Catalan (7) 7
Arabic (6) 6
Latvian (3) 3
Malay (3) 3
Welsh (3) 3
Amharic (1) 1
Azerbaijani (1) 1
Latin (1) 1
Pushto (1) 1
Vietnamese (1) 1
Zhuang (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1998, Lung biology in health and disease, ISBN 9780824701673, Volume 120, xviii, 493
Five-Lipoxygenase Products in Asthma offers an authoritative examination of the biochemistry, basic pharmacology, and clinical pharmacology of the leukotrienes... 
Chemotherapy | drug therapy | Pathophysiology | Leukotrienes | metabolism | Arachidonate 5-Lipoxygenase | Lipoxygenase Inhibitors | therapeutic use | antagonists & inhibitors | Asthma | Receptors, Leukotriene | Metabolism
Book
Journal of Medicinal Chemistry, ISSN 0022-2623, 02/2016, Volume 59, Issue 4, pp. 1271 - 1298
Bromodomains, small protein modules that recognize acetylated lysine on histones, play a significant role in the epigenome, where they function as "readers"... 
CHEMISTRY, MEDICINAL | SWI/SNF COMPLEXES | SMALL-MOLECULE INHIBITORS | PROSTATE-CANCER | SELECTIVE INHIBITORS | GENE-EXPRESSION | CHEMICAL PROBE | TUMOR-SUPPRESSOR | BET INHIBITORS | HISTONE ACETYLTRANSFERASE | PHD FINGER | Small Molecule Libraries - pharmacology | Antigens, Nuclear - metabolism | Humans | Drug Discovery - methods | CREB-Binding Protein - antagonists & inhibitors | Chromosomal Proteins, Non-Histone - antagonists & inhibitors | DNA-Binding Proteins - metabolism | CREB-Binding Protein - metabolism | Protein Processing, Post-Translational - drug effects | Adaptor Proteins, Signal Transducing - antagonists & inhibitors | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Lysine - metabolism | Protein-Serine-Threonine Kinases - metabolism | RNA-Binding Proteins - antagonists & inhibitors | Nerve Tissue Proteins - antagonists & inhibitors | ATPases Associated with Diverse Cellular Activities | DNA-Binding Proteins - antagonists & inhibitors | Chromosomal Proteins, Non-Histone - metabolism | Carrier Proteins - antagonists & inhibitors | Adenosine Triphosphatases - metabolism | Models, Molecular | Nuclear Proteins - metabolism | Transcription Factors - antagonists & inhibitors | Nerve Tissue Proteins - metabolism | Transcription Factors - metabolism | Adenosine Triphosphatases - antagonists & inhibitors | DNA Helicases - metabolism | Small Molecule Libraries - chemistry | Acetylation - drug effects | Animals | Carrier Proteins - metabolism | Nuclear Proteins - antagonists & inhibitors | DNA Helicases - antagonists & inhibitors | Histones - metabolism | Adaptor Proteins, Signal Transducing - metabolism | RNA-Binding Proteins - metabolism | Index Medicus
Journal Article
2002, Current topics in microbiology and immunology, ISBN 3540430962, Volume 268., 213
Book
The Journal of Immunology, ISSN 0022-1767, 01/2004, Volume 172, Issue 1, pp. 567 - 576
The signaling mechanism by which the anti-inflammatory cytokine IL-10 mediates suppression of proinflammatory cytokine synthesis remains largely unknown.... 
RHEUMATOID-ARTHRITIS | TUMOR-NECROSIS-FACTOR | DNA-BINDING | HUMAN NEUTROPHILS | TYROSINE PHOSPHORYLATION | INTERLEUKIN-10 RECEPTOR | GENE-EXPRESSION | KAPPA-B-ALPHA | IMMUNOLOGY | HUMAN MONOCYTES | MONONUCLEAR PHAGOCYTES | Protein Binding - genetics | Protein Biosynthesis | Interleukin-6 - antagonists & inhibitors | Humans | Tumor Necrosis Factor-alpha - genetics | Immunoglobulins - genetics | Lipopolysaccharides - antagonists & inhibitors | RNA, Messenger - metabolism | Suppressor of Cytokine Signaling Proteins | Repressor Proteins - antagonists & inhibitors | Antigens, CD - metabolism | Trans-Activators - physiology | Protein Tyrosine Phosphatases - antagonists & inhibitors | RNA, Messenger - biosynthesis | Protein Tyrosine Phosphatases - genetics | Inflammation Mediators - physiology | Glycoproteins - genetics | DNA-Binding Proteins - physiology | Protein Tyrosine Phosphatases - biosynthesis | DNA-Binding Proteins - antagonists & inhibitors | Signal Transduction - genetics | DNA - metabolism | Down-Regulation - genetics | Macrophages - metabolism | Protein Tyrosine Phosphatase, Non-Receptor Type 2 | Repressor Proteins - biosynthesis | Up-Regulation - immunology | Interleukin-10 - antagonists & inhibitors | Lipopolysaccharides - pharmacology | Adenoviruses, Human - genetics | Interleukin-10 - immunology | Tumor Necrosis Factor-alpha - biosynthesis | Phosphorylation | Tissue Inhibitor of Metalloproteinase-1 - biosynthesis | Antigens, CD - biosynthesis | Receptors, Cell Surface | Receptors, IgG - biosynthesis | Receptors, IgG - antagonists & inhibitors | Interleukin-10 - physiology | Signal Transduction - immunology | Tissue Inhibitor of Metalloproteinase-1 - metabolism | Signaling Lymphocytic Activation Molecule Family Member 1 | Receptors, Tumor Necrosis Factor - antagonists & inhibitors | RNA, Messenger - antagonists & inhibitors | Receptors, Tumor Necrosis Factor, Type II | Trans-Activators - genetics | Inflammation Mediators - antagonists & inhibitors | Trans-Activators - biosynthesis | Immunoglobulins - biosynthesis | Macrophages - immunology | Inflammation Mediators - immunology | Receptors, Tumor Necrosis Factor - metabolism | Immune Sera - pharmacology | Proteins - physiology | Cells, Cultured | Glycoproteins - antagonists & inhibitors | Histocompatibility Antigens Class II - biosynthesis | Tissue Inhibitor of Metalloproteinase-1 - antagonists & inhibitors | Transcription Factors - antagonists & inhibitors | Transcription Factors - biosynthesis | Up-Regulation - genetics | DNA-Binding Proteins - genetics | DNA - antagonists & inhibitors | Glycoproteins - biosynthesis | Suppressor of Cytokine Signaling 3 Protein | Down-Regulation - immunology | Interleukin-6 - biosynthesis | Receptors, Tumor Necrosis Factor - biosynthesis | STAT3 Transcription Factor | Trans-Activators - antagonists & inhibitors | Genetic Vectors | DNA-Binding Proteins - biosynthesis | Tumor Necrosis Factor-alpha - antagonists & inhibitors | SOCS-3 protein | Index Medicus | Abridged Index Medicus
Journal Article
2009, ISBN 1402095635, ix, 125
In 1971, J. Folkman published in the "New England Journal of Medicine" a hypothesis that tumor growth is angiogenesis-dependent. Folkman introduced the concept... 
Neovascularization | Blood-vessels | Growth | Neovascularization inhibitors | Tumors | Clinical & internal medicine | Treatment | Pathology | History of Science | Biomedicine | Cancer Research | Oncology | Biomedicine general | Cell Biology
Book
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
Summary Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary... 
Internal Medicine | STROKE | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | THERAPY | MYOCARDIAL-INFARCTION | AVAILABILITY | HEART-FAILURE | SELF-REPORT | ACUTE CORONARY SYNDROMES | MEDICINES | VALIDITY | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Epidemiology | Economic development | Community | Drug use | Index Medicus | Abridged Index Medicus | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
Journal Article
2010, Recent results in cancer research, ISBN 9783540782803, Volume 180., xiv, 231
All aspects from the bench to the bedside are considered in this examination of the latest developments in angiogenesis inhibition in cancer. The authors pay... 
Neovascularization inhibitors | Chemotherapy | Therapeutic use | Cancer | Oncology | Cancer Research | Medicine & Public Health | Hematology
Book
Nature Medicine, ISSN 1078-8956, 04/2013, Volume 19, Issue 4, pp. 446 - 451
Journal Article
Cancer Discovery, ISSN 2159-8274, 04/2017, Volume 7, Issue 4, pp. 400 - 409
Entrectinib, a potent oral inhibitor of the tyrosine kinases TRKA/B/C, ROS1, and ALK, was evaluated in two phase I studies in patients with advanced or... 
REARRANGEMENT | ONCOGENE | ONCOLOGY | ANALOG SECRETORY CARCINOMA | LANDSCAPE | KINASE FUSIONS | SARCOMAS | ETV6-NTRK3 GENE FUSION | CRIZOTINIB | GENOMIC ALTERATIONS | CLINICAL-RESPONSE | Benzamides - pharmacokinetics | Colorectal Neoplasms - genetics | Humans | Middle Aged | Receptor, trkA - antagonists & inhibitors | Male | Receptor, trkB - genetics | Indazoles - administration & dosage | Protein Kinase Inhibitors - adverse effects | Mammary Analogue Secretory Carcinoma - genetics | Dose-Response Relationship, Drug | Benzamides - administration & dosage | Membrane Glycoproteins - antagonists & inhibitors | Receptor, trkC - genetics | Anaplastic Lymphoma Kinase | Melanoma - genetics | Colorectal Neoplasms - drug therapy | Receptor, trkB - antagonists & inhibitors | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Benzamides - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Crizotinib | Protein Kinase Inhibitors - pharmacokinetics | Proto-Oncogene Proteins - antagonists & inhibitors | Pyridines - administration & dosage | Carcinoma, Non-Small-Cell Lung - genetics | Receptor, trkC - antagonists & inhibitors | Melanoma - pathology | Mammary Analogue Secretory Carcinoma - drug therapy | Membrane Glycoproteins - genetics | Protein Kinase Inhibitors - administration & dosage | Sequestosome-1 Protein - genetics | Pyrazoles - administration & dosage | Indazoles - pharmacokinetics | Receptor Protein-Tyrosine Kinases - genetics | Oncogene Proteins, Fusion - genetics | Melanoma - drug therapy | Adolescent | Receptor, trkA - genetics | Oncogene Proteins, Fusion - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Indazoles - adverse effects | Colorectal Neoplasms - pathology | Protein-Tyrosine Kinases - antagonists & inhibitors | Index Medicus
Journal Article
Genes and Development, ISSN 0890-9369, 05/2013, Volume 27, Issue 10, pp. 1101 - 1114
Tumorigenesis results from dysregulation of oncogenes and tumor suppressors that influence cellular proliferation, differentiation, apoptosis, and/or... 
Huwe1 | c-Myc | Mule | Ras | p21 | Miz1 | DNA-DAMAGE | KERATINOCYTE GROWTH | DEVELOPMENTAL BIOLOGY | CELL BIOLOGY | BASE EXCISION-REPAIR | HUWE1 UBIQUITIN LIGASE | NEGATIVE REGULATION | GENETICS & HEREDITY | ARF TUMOR-SUPPRESSOR | DIFFERENTIATION | MIZ-1 | HUMAN CANCER | Protein Inhibitors of Activated STAT - deficiency | Tetradecanoylphorbol Acetate - pharmacology | 9,10-Dimethyl-1,2-benzanthracene - pharmacology | Male | Protein Inhibitors of Activated STAT - metabolism | Cyclin-Dependent Kinase Inhibitor p15 - biosynthesis | Oncogene Protein p21(ras) - metabolism | Cyclin-Dependent Kinase Inhibitor p16 | Oncogene Protein p21(ras) - antagonists & inhibitors | Cyclin-Dependent Kinase Inhibitor p21 - genetics | Cell Transformation, Neoplastic - genetics | Cyclin-Dependent Kinase Inhibitor p15 - genetics | Nuclear Proteins - deficiency | Protein Inhibitors of Activated STAT - genetics | Cyclin-Dependent Kinase Inhibitor p21 - metabolism | Female | Nuclear Proteins - genetics | Protein Inhibitors of Activated STAT - antagonists & inhibitors | Skin Neoplasms - pathology | Cyclin-Dependent Kinase Inhibitor p21 - biosynthesis | Signal Transduction | Down-Regulation | Cells, Cultured | Ubiquitin-Protein Ligases - metabolism | Nuclear Proteins - metabolism | Skin Neoplasms - chemically induced | Proto-Oncogene Proteins c-myc - metabolism | Mice, Knockout | Skin Neoplasms - metabolism | Keratinocytes - pathology | Animals | Tumor Suppressor Protein p53 | Keratinocytes - drug effects | Keratinocytes - metabolism | Nuclear Proteins - antagonists & inhibitors | Proto-Oncogene Proteins c-myc - deficiency | Skin Neoplasms - genetics | Proto-Oncogene Proteins c-myc - antagonists & inhibitors | Ubiquitin-Protein Ligases - deficiency | Mice | Proto-Oncogene Proteins c-myc - genetics | Cyclin-Dependent Kinase Inhibitor p15 - metabolism | Genes, ras | Ubiquitin-Protein Ligases - genetics | Oncogene Protein p21(ras) - genetics | Carcinogenesis | Ras genes | Analysis | Index Medicus | Research Paper
Journal Article